COMPANY REGISTRATION NUMBER:
14876765
|
Filleted Unaudited Financial Statements |
|
|
Statement of Financial Position |
|
31 May 2025
Current assets
|
Debtors |
5 |
20,222 |
– |
|
Cash at bank and in hand |
2 |
3 |
|
-------- |
---- |
|
20,224 |
3 |
|
|
|
|
|
Creditors: amounts falling due within one year |
6 |
11,065 |
6,217 |
|
-------- |
------- |
|
Net current assets/(liabilities) |
9,159 |
(
6,214) |
|
------- |
------- |
|
Total assets less current liabilities |
9,159 |
(
6,214) |
|
------- |
------- |
|
Net assets/(liabilities) |
9,159 |
(
6,214) |
|
------- |
------- |
|
|
|
|
Capital and reserves
|
Called up share capital |
2 |
2 |
|
Profit and loss account |
9,157 |
(
6,216) |
|
------- |
------- |
|
Shareholders funds/(deficit) |
9,159 |
(
6,214) |
|
------- |
------- |
|
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements
.
These financial statements were approved by the
board of directors
and authorised for issue on
28 May 2026
, and are signed on behalf of the board by:
|
Mr A Chemmukkan |
Mr F Koliyeri |
|
Director |
Director |
|
|
Company registration number:
14876765
|
Notes to the Financial Statements |
|
Year ended 31 May 2025
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Flat 101, Orvis Court, 12 Mizzen Street, Barking, London, IG11 7RZ, England.
2.
Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The financial statements have been prepared on a going concern basis as the directors consider that there are no material uncertainties that may cast significant doubt about the company’s ability to continue as a going concern as this is the first period of trading. The directors will continue to support the company in the foreseeable future.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. There are no key estimates and assumptions that have a significant impact on the amounts recognised in the financial statements.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares. Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss. Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Debtors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.
Cash and cash equivalents
Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
Creditors
Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment.
4.
Employee numbers
The average number of persons employed by the company during the year amounted to
1
(2024: Nil).
5.
Debtors
|
2025 |
2024 |
|
£ |
£ |
|
Directors loan account |
15,119 |
– |
|
Other debtors |
5,103 |
– |
|
-------- |
---- |
|
20,222 |
– |
|
-------- |
---- |
|
|
|
6.
Creditors:
amounts falling due within one year
|
2025 |
2024 |
|
£ |
£ |
|
Accruals and deferred income |
2,636 |
1,000 |
|
Corporation tax |
7,261 |
– |
|
Social security and other taxes |
1,168 |
– |
|
Director loan accounts |
– |
5,217 |
|
-------- |
------- |
|
11,065 |
6,217 |
|
-------- |
------- |
|
|
|
7.
Directors' advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
|
2025 |
|
|
Balance brought forward |
Advances/ (credits) to the directors |
Amounts repaid |
Balance outstanding |
|
|
£ |
£ |
£ |
£ |
|
Mr A Chemmukkan |
(
5,217) |
53,893 |
(
33,557) |
15,119 |
|
|
------- |
-------- |
-------- |
-------- |
|
|
|
|
|
|
|
2024 |
|
|
Balance brought forward |
Advances/ (credits) to the directors |
Amounts repaid |
Balance outstanding |
|
|
£ |
£ |
£ |
£ |
|
Mr A Chemmukkan |
– |
24,615 |
(
29,832) |
(
5,217) |
|
|
---- |
-------- |
-------- |
------- |
|
|
|
|
|
|